Privia Health Group Inc (PRVA)vsTempus AI, Inc. Class A Common Stock (TEM)
PRVA
Privia Health Group Inc
$20.54
-2.33%
HEALTHCARE · Cap: $2.60B
TEM
Tempus AI, Inc. Class A Common Stock
$46.76
-4.24%
HEALTHCARE · Cap: $8.73B
Smart Verdict
WallStSmart Research — data-driven comparison
Privia Health Group Inc generates 67% more annual revenue ($2.12B vs $1.27B). PRVA leads profitability with a 108.0% profit margin vs -19.3%. PRVA earns a higher WallStSmart Score of 48/100 (D+).
PRVA
Hold48
out of 100
Grade: D+
TEM
Avoid31
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-156.5%
Fair Value
$8.42
Current Price
$20.54
$12.12 premium
Intrinsic value data unavailable for TEM.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Keeps 108 of every $100 in revenue as profit
Earnings expanding 132.8% YoY
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
17.4% revenue growth
Revenue surging 83.0% year-over-year
Areas to Watch
ROE of 4.0% — below average capital efficiency
Operating margin of 2.1%
Premium valuation, high expectations priced in
Trading at 16.9x book value
0.0% earnings growth
ROE of -89.5% — below average capital efficiency
Negative free cash flow — burning cash
Comparative Analysis Report
WallStSmart ResearchBull Case : PRVA
The strongest argument for PRVA centers on Profit Margin, EPS Growth, Debt/Equity. Profitability is solid with margins at 108.0% and operating margin at 2.1%. Revenue growth of 17.4% demonstrates continued momentum.
Bull Case : TEM
The strongest argument for TEM centers on Revenue Growth. Revenue growth of 83.0% demonstrates continued momentum.
Bear Case : PRVA
The primary concerns for PRVA are Return on Equity, Operating Margin, P/E Ratio. A P/E of 116.8x leaves little room for execution misses.
Bear Case : TEM
The primary concerns for TEM are Price/Book, EPS Growth, Return on Equity. Debt-to-equity of 2.63 is elevated, increasing financial risk.
Key Dynamics to Monitor
PRVA profiles as a growth stock while TEM is a hypergrowth play — different risk/reward profiles.
TEM is growing revenue faster at 83.0% — sustainability is the question.
PRVA generates stronger free cash flow (126M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
PRVA scores higher overall (48/100 vs 31/100), backed by strong 108.0% margins and 17.4% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Privia Health Group Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Privia Health Group, Inc. is a population health technology and medical practice management company in the United States.
Visit Website →Tempus AI, Inc. Class A Common Stock
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Tempus AI, Inc is a healthcare technology company. The company is headquartered in Chicago, Illinois.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?